Viemed Healthcare, Inc.
VMD · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.53 | -0.75 | 1.77 | 0.11 |
| FCF Yield | 1.51% | -4.40% | 1.01% | 0.61% |
| EV / EBITDA | 21.69 | 27.13 | 23.59 | 23.15 |
| Quality | ||||
| ROIC | 1.98% | 1.98% | 3.21% | 2.97% |
| Gross Margin | 57.69% | 56.28% | 59.54% | 59.26% |
| Cash Conversion Ratio | 5.10 | 3.88 | 1.05 | 3.39 |
| Growth | ||||
| Revenue 3-Year CAGR | 14.49% | 15.55% | 16.79% | 17.33% |
| Free Cash Flow Growth | 132.66% | -499.91% | 81.18% | 39.66% |
| Safety | ||||
| Net Debt / EBITDA | -1.10 | -0.33 | -0.83 | -0.34 |
| Interest Coverage | 34.18 | 21.46 | 43.89 | 25.01 |
| Efficiency | ||||
| Inventory Turnover | 6.17 | 5.73 | 5.68 | 5.48 |
| Cash Conversion Cycle | 24.64 | 12.48 | 18.55 | 19.92 |